MELAS and reversible vasoconstriction of the major cerebral arteries

Internal Medicine

Volumn 52, Issue 12, 2013, Pages 1389-1392

  Yoshida, Takeshi ^a   Ouchi, Atsushi ^b   Miura, Daisuke ^b   Shimoji, Kunihiro ^b   Kinjo, Kazushi ^b   Sueyoshi, Takeshi ^a   Jonosono, Manabu ^a   Rajput, Vijay ^c  

^a Okinawa Prefectural Chubu Hospital   (Japan)

^b Okinawa Hokubu Hospital   (Japan)

^c Cooper Medical School of Rowan University ^*  (United States)

Author keywords

L arginine; Lactic acidosis; Mitochondrial encephalopathy; Reversible cerebral vasoconstriction syndrome; Stroke like episode

Indexed keywords

ARGININE; CYCLOSPORIN; DIAZEPAM; LACTIC ACID; PHENYTOIN; PYRUVIC ACID; UBIDECARENONE;

ADULT; ARTICLE; CASE REPORT; COMATOSE PATIENT; COMPUTER ASSISTED TOMOGRAPHY; DIFFUSION COEFFICIENT; DIFFUSION WEIGHTED IMAGING; ELECTROENCEPHALOGRAPHY; FEMALE; FEVER; FOLLOW UP; HEADACHE; HUMAN; MAGNETIC RESONANCE ANGIOGRAPHY; MELAS SYNDROME; METABOLIC ACIDOSIS; NAUSEA; NEPHROTIC SYNDROME; NUCLEAR MAGNETIC RESONANCE IMAGING; REVERSIBLE CEREBRAL VASOCONSTRICTION SYNDROME;

ADULT; DIFFUSION MAGNETIC RESONANCE IMAGING; DNA, MITOCHONDRIAL; FEMALE; HUMANS; MAGNETIC RESONANCE ANGIOGRAPHY; MELAS SYNDROME; POINT MUTATION; REMISSION INDUCTION; SEIZURES; VASOSPASM, INTRACRANIAL;

EID: 84878987706     PISSN: 09182918     EISSN: 13497235     Source Type: Journal    
DOI: 10.2169/internalmedicine.52.0188     Document Type: Article

References (14)

1. Palvlakis SG, Phillips PC, DiMauro S, et al. Mitochondrial myopathy, encephalopathy, lactic acidosis, and stroke like episodes: a distinctive clinical syndrome. Ann Neurol 16: 481-488, 1984.
2. Ohama E, Ohara S, Ikuta F, Tanaka K, Nishizawa M, Miyatake T. Mitochondrial angiopathy in the cerebral blood vessels of MELAS (mitochondrial myopathy, encephalopathy, lactic acidosis and strokelike episodes). No To Shinkei 40: 109-118, 1988.
3. Iizuka T, Sakai F, Suzuki N, et al. Neuronal hyperexcitability in stroke-like episodes of MELAS syndrome. Neurology 59: 816- 824, 2002.
4. Iizuka T. Pathogenesis and treatment of stroke-like episodes in MELAS. Clin Neurol 48: 1006-1009, 2008.
5. Koga Y, Akita Y, Junko N, et al. Endothelial dysfunction in MELAS improved by l-arginine supplementation. Neurology 66: 1766-1769, 2006.
6. Iizuka T, Goto Y, Miyakawa S, et al. Progressive carotid artery stenosis with a novel tRNA phenylalanine mitochondrial DNA mutation. J Neurol Sci 278: 35-40, 2009.
7. Calabrese LH, Dodick DW, Schwedt TJ, Singhal AB. Narrative review: reversible cerebral vasoconstriction syndromes. Ann Intern Med 146: 34-44, 2007.
8. Ducros A, Boukobza M, Porcher R, Sarov M, Valade D, Bousser MG. The clinical and radiological spectrum of reversible cerebral vasoconstriction syndrome. A prospective series of 67 patients. Brain 130 (Pt 12): 3091-3101, 2007. Epub 2007 Nov 19.
9. Hinchey J, Chaves C, Appignani B, et al. A reversible posterior leukoencephalopathy syndrome. N Engl J Med 334: 494-500, 1996, DOI: 10.1056/NEJM199602223340803
10. Truwit CL, Denaro CP, Lake JR, DeMarco T. MR imaging of reversible cyclosporin A-induced neurotoxicity. AJNR Am J Neuroradiol 12: 651-659, 1991.
11. Noguchi A, Shoji Y, Matsumori M, Komatsu K, Takada G. Strokelike episode involving a cerebral artery in a patient with MELAS. Pediatr Neurol 33: 70-71, 2005. Epub 2005 Apr 13.
12. Tani E. Molecular mechanisms involved in development of cerebral vasospasm. Neurosurg Focus 12: ECP1, 2002.
13. Dietrich HH, Dacey RG Jr. Molecular keys to the problems of cerebral vasospasm. Neurosurgery 46: 517-530, 2000.
14. Koga Y, Akita Y, Nishioka J, et al. L-arginine improves the symptoms of strokelike episodes in MELAS. Neurology 64: 710-712, 2005.